AI Drug Development Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: A7B938F60C73EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of AI Drug Development in Global, including the following market information:

Global AI Drug Development Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global AI Drug Development market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Design Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of AI Drug Development include Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg?Inc. and Numerate, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the AI Drug Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global AI Drug Development Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global AI Drug Development Market Segment Percentages, by Type, 2021 (%)

• Drug Design
• Drug Synthesis
• Other

Global AI Drug Development Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global AI Drug Development Market Segment Percentages, by Application, 2021 (%)

• Tumor
• Nervous System
• Other

Global AI Drug Development Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global AI Drug Development Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies AI Drug Development revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies AI Drug Development revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Insilico Medicine
• Cyclica
• XtalPi Inc.
• Exscientia Limited
• AiCure, LLC
• Atomwise
• Biovista Inc.
• Breg?Inc.
• Numerate
• Cloud Pharmaceuticals
• IBM
• NuMedii
• BenevolentAI
• Lam Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 AI Drug Development Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global AI Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AI DRUG DEVELOPMENT OVERALL MARKET SIZE

2.1 Global AI Drug Development Market Size: 2021 VS 2028
2.2 Global AI Drug Development Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top AI Drug Development Players in Global Market
3.2 Top Global AI Drug Development Companies Ranked by Revenue
3.3 Global AI Drug Development Revenue by Companies
3.4 Top 3 and Top 5 AI Drug Development Companies in Global Market, by Revenue in 2021
3.5 Global Companies AI Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 AI Drug Development Players in Global Market
  3.6.1 List of Global Tier 1 AI Drug Development Companies
  3.6.2 List of Global Tier 2 and Tier 3 AI Drug Development Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global AI Drug Development Market Size Markets, 2021 & 2028
  4.1.2 Drug Design
  4.1.3 Drug Synthesis
  4.1.4 Other
4.2 By Type - Global AI Drug Development Revenue & Forecasts
  4.2.1 By Type - Global AI Drug Development Revenue, 2017-2022
  4.2.2 By Type - Global AI Drug Development Revenue, 2023-2028
  4.2.3 By Type - Global AI Drug Development Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global AI Drug Development Market Size, 2021 & 2028
  5.1.2 Tumor
  5.1.3 Nervous System
  5.1.4 Other
5.2 By Application - Global AI Drug Development Revenue & Forecasts
  5.2.1 By Application - Global AI Drug Development Revenue, 2017-2022
  5.2.2 By Application - Global AI Drug Development Revenue, 2023-2028
  5.2.3 By Application - Global AI Drug Development Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global AI Drug Development Market Size, 2021 & 2028
6.2 By Region - Global AI Drug Development Revenue & Forecasts
  6.2.1 By Region - Global AI Drug Development Revenue, 2017-2022
  6.2.2 By Region - Global AI Drug Development Revenue, 2023-2028
  6.2.3 By Region - Global AI Drug Development Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America AI Drug Development Revenue, 2017-2028
  6.3.2 US AI Drug Development Market Size, 2017-2028
  6.3.3 Canada AI Drug Development Market Size, 2017-2028
  6.3.4 Mexico AI Drug Development Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe AI Drug Development Revenue, 2017-2028
  6.4.2 Germany AI Drug Development Market Size, 2017-2028
  6.4.3 France AI Drug Development Market Size, 2017-2028
  6.4.4 U.K. AI Drug Development Market Size, 2017-2028
  6.4.5 Italy AI Drug Development Market Size, 2017-2028
  6.4.6 Russia AI Drug Development Market Size, 2017-2028
  6.4.7 Nordic Countries AI Drug Development Market Size, 2017-2028
  6.4.8 Benelux AI Drug Development Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia AI Drug Development Revenue, 2017-2028
  6.5.2 China AI Drug Development Market Size, 2017-2028
  6.5.3 Japan AI Drug Development Market Size, 2017-2028
  6.5.4 South Korea AI Drug Development Market Size, 2017-2028
  6.5.5 Southeast Asia AI Drug Development Market Size, 2017-2028
  6.5.6 India AI Drug Development Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America AI Drug Development Revenue, 2017-2028
  6.6.2 Brazil AI Drug Development Market Size, 2017-2028
  6.6.3 Argentina AI Drug Development Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa AI Drug Development Revenue, 2017-2028
  6.7.2 Turkey AI Drug Development Market Size, 2017-2028
  6.7.3 Israel AI Drug Development Market Size, 2017-2028
  6.7.4 Saudi Arabia AI Drug Development Market Size, 2017-2028
  6.7.5 UAE AI Drug Development Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Insilico Medicine
  7.1.1 Insilico Medicine Corporate Summary
  7.1.2 Insilico Medicine Business Overview
  7.1.3 Insilico Medicine AI Drug Development Major Product Offerings
  7.1.4 Insilico Medicine AI Drug Development Revenue in Global Market (2017-2022)
  7.1.5 Insilico Medicine Key News
7.2 Cyclica
  7.2.1 Cyclica Corporate Summary
  7.2.2 Cyclica Business Overview
  7.2.3 Cyclica AI Drug Development Major Product Offerings
  7.2.4 Cyclica AI Drug Development Revenue in Global Market (2017-2022)
  7.2.5 Cyclica Key News
7.3 XtalPi Inc.
  7.3.1 XtalPi Inc. Corporate Summary
  7.3.2 XtalPi Inc. Business Overview
  7.3.3 XtalPi Inc. AI Drug Development Major Product Offerings
  7.3.4 XtalPi Inc. AI Drug Development Revenue in Global Market (2017-2022)
  7.3.5 XtalPi Inc. Key News
7.4 Exscientia Limited
  7.4.1 Exscientia Limited Corporate Summary
  7.4.2 Exscientia Limited Business Overview
  7.4.3 Exscientia Limited AI Drug Development Major Product Offerings
  7.4.4 Exscientia Limited AI Drug Development Revenue in Global Market (2017-2022)
  7.4.5 Exscientia Limited Key News
7.5 AiCure, LLC
  7.5.1 AiCure, LLC Corporate Summary
  7.5.2 AiCure, LLC Business Overview
  7.5.3 AiCure, LLC AI Drug Development Major Product Offerings
  7.5.4 AiCure, LLC AI Drug Development Revenue in Global Market (2017-2022)
  7.5.5 AiCure, LLC Key News
7.6 Atomwise
  7.6.1 Atomwise Corporate Summary
  7.6.2 Atomwise Business Overview
  7.6.3 Atomwise AI Drug Development Major Product Offerings
  7.6.4 Atomwise AI Drug Development Revenue in Global Market (2017-2022)
  7.6.5 Atomwise Key News
7.7 Biovista Inc.
  7.7.1 Biovista Inc. Corporate Summary
  7.7.2 Biovista Inc. Business Overview
  7.7.3 Biovista Inc. AI Drug Development Major Product Offerings
  7.7.4 Biovista Inc. AI Drug Development Revenue in Global Market (2017-2022)
  7.7.5 Biovista Inc. Key News
7.8 Breg?Inc.
  7.8.1 Breg?Inc. Corporate Summary
  7.8.2 Breg?Inc. Business Overview
  7.8.3 Breg?Inc. AI Drug Development Major Product Offerings
  7.8.4 Breg?Inc. AI Drug Development Revenue in Global Market (2017-2022)
  7.8.5 Breg?Inc. Key News
7.9 Numerate
  7.9.1 Numerate Corporate Summary
  7.9.2 Numerate Business Overview
  7.9.3 Numerate AI Drug Development Major Product Offerings
  7.9.4 Numerate AI Drug Development Revenue in Global Market (2017-2022)
  7.9.5 Numerate Key News
7.10 Cloud Pharmaceuticals
  7.10.1 Cloud Pharmaceuticals Corporate Summary
  7.10.2 Cloud Pharmaceuticals Business Overview
  7.10.3 Cloud Pharmaceuticals AI Drug Development Major Product Offerings
  7.10.4 Cloud Pharmaceuticals AI Drug Development Revenue in Global Market (2017-2022)
  7.10.5 Cloud Pharmaceuticals Key News
7.11 IBM
  7.11.1 IBM Corporate Summary
  7.11.2 IBM Business Overview
  7.11.3 IBM AI Drug Development Major Product Offerings
  7.11.4 IBM AI Drug Development Revenue in Global Market (2017-2022)
  7.11.5 IBM Key News
7.12 NuMedii
  7.12.1 NuMedii Corporate Summary
  7.12.2 NuMedii Business Overview
  7.12.3 NuMedii AI Drug Development Major Product Offerings
  7.12.4 NuMedii AI Drug Development Revenue in Global Market (2017-2022)
  7.12.5 NuMedii Key News
7.13 BenevolentAI
  7.13.1 BenevolentAI Corporate Summary
  7.13.2 BenevolentAI Business Overview
  7.13.3 BenevolentAI AI Drug Development Major Product Offerings
  7.13.4 BenevolentAI AI Drug Development Revenue in Global Market (2017-2022)
  7.13.5 BenevolentAI Key News
7.14 Lam Therapeutics
  7.14.1 Lam Therapeutics Corporate Summary
  7.14.2 Lam Therapeutics Business Overview
  7.14.3 Lam Therapeutics AI Drug Development Major Product Offerings
  7.14.4 Lam Therapeutics AI Drug Development Revenue in Global Market (2017-2022)
  7.14.5 Lam Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. AI Drug Development Market Opportunities & Trends in Global Market
Table 2. AI Drug Development Market Drivers in Global Market
Table 3. AI Drug Development Market Restraints in Global Market
Table 4. Key Players of AI Drug Development in Global Market
Table 5. Top AI Drug Development Players in Global Market, Ranking by Revenue (2021)
Table 6. Global AI Drug Development Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global AI Drug Development Revenue Share by Companies, 2017-2022
Table 8. Global Companies AI Drug Development Product Type
Table 9. List of Global Tier 1 AI Drug Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 AI Drug Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global AI Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - AI Drug Development Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - AI Drug Development Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global AI Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - AI Drug Development Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - AI Drug Development Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global AI Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global AI Drug Development Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global AI Drug Development Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America AI Drug Development Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America AI Drug Development Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe AI Drug Development Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe AI Drug Development Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia AI Drug Development Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia AI Drug Development Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America AI Drug Development Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America AI Drug Development Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa AI Drug Development Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa AI Drug Development Revenue, (US$, Mn), 2023-2028
Table 30. Insilico Medicine Corporate Summary
Table 31. Insilico Medicine AI Drug Development Product Offerings
Table 32. Insilico Medicine AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 33. Cyclica Corporate Summary
Table 34. Cyclica AI Drug Development Product Offerings
Table 35. Cyclica AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 36. XtalPi Inc. Corporate Summary
Table 37. XtalPi Inc. AI Drug Development Product Offerings
Table 38. XtalPi Inc. AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 39. Exscientia Limited Corporate Summary
Table 40. Exscientia Limited AI Drug Development Product Offerings
Table 41. Exscientia Limited AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 42. AiCure, LLC Corporate Summary
Table 43. AiCure, LLC AI Drug Development Product Offerings
Table 44. AiCure, LLC AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 45. Atomwise Corporate Summary
Table 46. Atomwise AI Drug Development Product Offerings
Table 47. Atomwise AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 48. Biovista Inc. Corporate Summary
Table 49. Biovista Inc. AI Drug Development Product Offerings
Table 50. Biovista Inc. AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 51. Breg?Inc. Corporate Summary
Table 52. Breg?Inc. AI Drug Development Product Offerings
Table 53. Breg?Inc. AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 54. Numerate Corporate Summary
Table 55. Numerate AI Drug Development Product Offerings
Table 56. Numerate AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 57. Cloud Pharmaceuticals Corporate Summary
Table 58. Cloud Pharmaceuticals AI Drug Development Product Offerings
Table 59. Cloud Pharmaceuticals AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 60. IBM Corporate Summary
Table 61. IBM AI Drug Development Product Offerings
Table 62. IBM AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 63. NuMedii Corporate Summary
Table 64. NuMedii AI Drug Development Product Offerings
Table 65. NuMedii AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 66. BenevolentAI Corporate Summary
Table 67. BenevolentAI AI Drug Development Product Offerings
Table 68. BenevolentAI AI Drug Development Revenue (US$, Mn), (2017-2022)
Table 69. Lam Therapeutics Corporate Summary
Table 70. Lam Therapeutics AI Drug Development Product Offerings
Table 71. Lam Therapeutics AI Drug Development Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. AI Drug Development Segment by Type in 2021
Figure 2. AI Drug Development Segment by Application in 2021
Figure 3. Global AI Drug Development Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global AI Drug Development Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global AI Drug Development Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by AI Drug Development Revenue in 2021
Figure 8. By Type - Global AI Drug Development Revenue Market Share, 2017-2028
Figure 9. By Application - Global AI Drug Development Revenue Market Share, 2017-2028
Figure 10. By Region - Global AI Drug Development Revenue Market Share, 2017-2028
Figure 11. By Country - North America AI Drug Development Revenue Market Share, 2017-2028
Figure 12. US AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 13. Canada AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe AI Drug Development Revenue Market Share, 2017-2028
Figure 16. Germany AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 17. France AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 19. Italy AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 20. Russia AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia AI Drug Development Revenue Market Share, 2017-2028
Figure 24. China AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 25. Japan AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 28. India AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America AI Drug Development Revenue Market Share, 2017-2028
Figure 30. Brazil AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa AI Drug Development Revenue Market Share, 2017-2028
Figure 33. Turkey AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 34. Israel AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 36. UAE AI Drug Development Revenue, (US$, Mn), 2017-2028
Figure 37. Insilico Medicine AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cyclica AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. XtalPi Inc. AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Exscientia Limited AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AiCure, LLC AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Atomwise AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biovista Inc. AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Breg?Inc. AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Numerate AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cloud Pharmaceuticals AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. IBM AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. NuMedii AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BenevolentAI AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lam Therapeutics AI Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)